Testosterone Delivery Options in 2026: Injections, Gels, Pellets & Beyond
Mark Holthouse, MD

Join Dr. Mark Holthouse for this webinar as he discusses testosterone delivery options for men and women, the differences between testosterone replacement and testosterone optimization, and more.
Register to learn more about:
- A deep dive into testosterone delivery methods in addition to their advantages and disadvantages
- How testosterone therapy has and continues to evolve
- The importance of personalized care when it comes to hormone therapy
- Androgen metabolism measurement with the DUTCH Test
This session is designed for clinicians to gain a deeper understanding of testosterone delivery options, their benefits and risks, and how the DUTCH Test can help with measurement and monitoring.
About the Speaker
Mark Holthouse, MD has practiced family and functional medicine for over three decades, specializing in men's and women's hormones, peptides, and longevity medicine. Among the first cohort to receive IFM certification in functional medicine, he has taught the men's hormone advanced module for 14 years and served as a faculty member at Loma Linda University School of Medicine, where he taught preventive cardiology. His integrative approach combines peptide therapy, lifestyle foundations, hormone optimization, and cardiometabolic health into a comprehensive longevity program. Dr. Holthouse currently sees clients full time and serves as Chief Medical Officer at the Functional Medicine Institute. Outside of his clinical role, he continues to teach and educate colleagues and patients alike.
New DUTCH Providers are eligible for 50% off their first five test kits.* Become a DUTCH Provider today!
Please Note: The contents of this webinar are for educational and informational purposes only. The information is not to be interpreted as, or mistaken for, clinical advice. Please consult a medical professional or healthcare provider for medical advice, diagnoses, or treatment.
Disclaimer: Special offer of 50% OFF first five kits is invalid 60 days after new provider registration.
TAGS
Women's Health
Men's Health
Testosterone
Hormone Replacement Therapy (HRT)